CABOT CORP financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
CBT on NYSE
Location
Boston, MA
Fiscal year end
30 September
Latest financial report
04 Feb 2026

Quick Takeaways

  • CBT - CABOT CORP financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 22%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-33%</span>.
  • Most recent SEC facts end date: 02 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-02) highlights Return On Equity 21.8%, Return On Assets 10.2%, and Operating Margin 15.2%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

66.0/100

Balanced Confidence high

Return On Equity

22%

Metric score 81.3/100

Return On Assets

10%

Metric score 100.0/100

Financial Health

Current Ratio
1.67x
Quick Ratio
0.97x
Debt to Equity
0.65x

Strengths

Return On Equity, Return On Assets, and Current Ratio

Watchpoints

Revenues YoY and NetIncomeLoss YoY

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Equity 22% -33%
Return On Assets 10% -27%
Operating Margin 15% +4%

Financial Health

Metric Latest value YoY change
Current Ratio 1.67x -17%
Quick Ratio 0.97x -15%
Debt-to-equity 0.65x

Growth

Metric Latest value YoY change
Revenues YoY -9.6%
NetIncomeLoss YoY -26%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 52,221,604 -3.7%
Common Stock, Shares, Outstanding 52,215,581 -3.7%
Common Stock, Value, Issued $52,000,000 -3.7%
Weighted Average Number of Shares Outstanding, Basic 52,700,000 -2.9%
Weighted Average Number of Shares Outstanding, Diluted 52,900,000 -3.8%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $58,000,000 -6.5%
Operating Income (Loss) $595,000,000 -6%
Income Tax Expense (Benefit) $192,000,000 +63%
Earnings Per Share, Basic 5.76 -24%
Earnings Per Share, Diluted 5.72 -24%
Cash and Cash Equivalents, at Carrying Value $230,000,000 +26%
Inventory, Net $503,000,000 -6.2%
Assets, Current $1,457,000,000 -2.6%
Deferred Income Tax Assets, Net $179,000,000 -15%
Property, Plant and Equipment, Net $1,727,000,000 +11%
Goodwill $136,000,000 +7.1%
Other Assets, Noncurrent $187,000,000 +2.7%
Assets $3,757,000,000 +3.2%
Liabilities, Current $874,000,000 +17%
Deferred Income Tax Liabilities, Net $43,000,000 +10%
Other Liabilities, Noncurrent $257,000,000 +2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $310,000,000 +32%
Retained Earnings (Accumulated Deficit) $1,836,000,000 +3.6%
Stockholders' Equity Attributable to Parent $1,575,000,000 +15%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1,729,000,000 +14%
Liabilities and Equity $3,757,000,000 +3.2%
Share-based Payment Arrangement, Noncash Expense $3,000,000 -62%
Other Noncash Income (Expense) $10,000,000
Net Cash Provided by (Used in) Operating Activities $126,000,000 +1.6%
Net Cash Provided by (Used in) Financing Activities $92,000,000 -283%
Net Cash Provided by (Used in) Investing Activities $69,000,000 +34%
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 52,335,266 -3.7%
Common Stock, Par or Stated Value Per Share 1 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $28,000,000 +30%
Payments to Acquire Property, Plant, and Equipment $69,000,000 -10%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $458,000,000 +69%
Property, Plant and Equipment, Gross $4,471,000,000 +10%
Deferred Income Tax Expense (Benefit) $2,000,000
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 2,000,000 0%
Preferred Stock, Shares Outstanding 0
Amortization of Intangible Assets $2,000,000 0%
Depreciation, Depletion and Amortization $41,000,000 +11%
Interest Expense $76,000,000 -1.3%
Preferred Stock, Par or Stated Value Per Share 1 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY